CVS Health (CVS) named Ed DeVaney president of the company’s CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report to Prem Shah ...

Barclays analyst Andrew Mok CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $73.00. The company’s shares closed yesterday at $63.22.

Feb 12 (Reuters) - CVS Health (CVS.N), opens new tab beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that largely met expectations, hinting at an ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Feb 11 (Reuters) - CVS Health (CVS.N), opens new tab investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their impact on cost pressures in its ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

WOONSOCKET, R.I., Jan. 28, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced the launch of the CVS Health app. New features of the app will bring together all CVS Health has to offer ...

CVS Health recently acquired home healthcare agency, Signify Health, for a whopping $8 billion. With the biggest players across the healthcare industry interested in making an offer, I only expect ...

Microsoft and CVS Health have announced a new strategic alliance focusing on personalised care and accelerating digital transformation for the benefit of CVS customers and its employees.